MENU
+Compare
XOMA
Stock ticker: NASDAQ
AS OF
Jun 25 closing price
Price
$27.45
Change
-$0.14 (-0.51%)
Capitalization
328.49M

XOMA XOMA Royalty Corporation Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

Industry: #Biotechnology
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XOMA with price predictions
Jun 25, 2025

XOMA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for XOMA turned positive on June 24, 2025. Looking at past instances where XOMA's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 23, 2025. You may want to consider a long position or call options on XOMA as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

XOMA moved above its 50-day moving average on June 23, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMA advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XOMA moved out of overbought territory on June 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMA broke above its upper Bollinger Band on June 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XOMA entered a downward trend on June 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.883) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). XOMA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.020) settles around the average of (0.041) among similar stocks. P/S Ratio (27.855) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XOMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

XOMA is expected to report earnings to fall 429.17% to -19 cents per share on August 06

XOMA Royalty Corporation XOMA Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
Q2'24
Beat
by $1.10
The last earnings report on May 13 showed earnings per share of 5 cents, beating the estimate of -28 cents. With 50.68K shares outstanding, the current market capitalization sits at 328.49M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGLX12.07N/A
N/A
MassMutual Small Cap Gr Eq Adm
FUFRX24.32N/A
N/A
Franklin Utilities R6
FSTLX33.15N/A
N/A
Federated Hermes MDT Large Cap Value R6
NSFJX13.33N/A
N/A
Natixis Target Retirement 2045 N
FIKJX17.24N/A
N/A
Fidelity Advisor Real Estate Z

XOMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
-0.51%
SYRE - XOMA
39%
Loosely correlated
+2.01%
OCUL - XOMA
38%
Loosely correlated
+1.10%
GBIO - XOMA
38%
Loosely correlated
-1.51%
NAUT - XOMA
37%
Loosely correlated
+10.50%
ZNTL - XOMA
37%
Loosely correlated
-2.96%
More